Methadone, bupernorphine and COVID-19, with Nicky Kalk and Caroline Copeland

Methadone, bupernorphine and COVID-19, with Nicky Kalk and Caroline Copeland

Ever wondered how the pandemic affected opioid treatment and related deaths? Dr. Nicky Kalk and Dr. Caroline Copeland are here to break it down for you. In this episode of 'Addictions Edited', they dive into their research on methadone and buprenorphine-related deaths during the COVID-19 lockdowns. The conversation kicks off with a look at the expected versus actual number of deaths during this tumultuous period.

You'll hear how the UK's response to Hurricane Katrina influenced emergency measures, such as providing larger take-home supplies of opioid agonist medications. Instead of the usual supervised consumption, many people were given two weeks' worth of medication to take home. This shift in practice had a significant impact on overdose rates and access to treatment. Nicky and Caroline also explore the protective role that treatment can play, even when faced with the risk of medication diversion.

They discuss how their findings challenged their own thinking about overdose risks among those not in treatment. Finally, the episode wraps up with a broader look at how the pandemic has changed the landscape for people seeking addiction treatment. It's a must-listen for anyone interested in understanding the complexities of addiction treatment during a public health crisis.